Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy S Major

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosusAleksandar K Stanic, Charles M Stein, Adam C Morgan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2003
Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transportersYan Ru Su, Hiroyuki Ishiguro, Amy S Major, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 2, 2016
Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α InhibitionLin Zhu, Ilaria Giunzioni, Hagai Tavori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient miceAmy S Major, Michael T Wilson, Jennifer L McCaleb, et al.
Journal of Molecular and Cellular Cardiology|July 26, 2005
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 miceMichael E Burleigh, Vladimir R Babaev, Patricia G Yancey, et al.
Atherosclerosis|November 19, 2010
The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) miceYanice V Mendez-Fernandez, Bonnie G Stevenson, Cody J Diehl, et al.
The Journal of Biological Chemistry|September 14, 2010
Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- miceAshley J Wilhelm, Manal Zabalawi, John S Owen, et al.
Annals of the Rheumatic Diseases|September 29, 2011
Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) miceSander I van Leuven, Yanice V Mendez-Fernandez, Ashley J Wilhelm, et al.
The Journal of Pathology|September 4, 2015
Local effects of human PCSK9 on the atherosclerotic lesionIlaria Giunzioni, Hagai Tavori, Roman Covarrubias, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 17, 2009
Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunityAshley J Wilhelm, Manal Zabalawi, Jason M Grayson, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosusAleksandar K Stanic, Charles M Stein, Adam C Morgan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2003
Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transportersYan Ru Su, Hiroyuki Ishiguro, Amy S Major, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 2, 2016
Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α InhibitionLin Zhu, Ilaria Giunzioni, Hagai Tavori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient miceAmy S Major, Michael T Wilson, Jennifer L McCaleb, et al.
Journal of Molecular and Cellular Cardiology|July 26, 2005
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 miceMichael E Burleigh, Vladimir R Babaev, Patricia G Yancey, et al.
Atherosclerosis|November 19, 2010
The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) miceYanice V Mendez-Fernandez, Bonnie G Stevenson, Cody J Diehl, et al.
The Journal of Biological Chemistry|September 14, 2010
Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- miceAshley J Wilhelm, Manal Zabalawi, John S Owen, et al.
Annals of the Rheumatic Diseases|September 29, 2011
Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) miceSander I van Leuven, Yanice V Mendez-Fernandez, Ashley J Wilhelm, et al.
The Journal of Pathology|September 4, 2015
Local effects of human PCSK9 on the atherosclerotic lesionIlaria Giunzioni, Hagai Tavori, Roman Covarrubias, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 17, 2009
Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunityAshley J Wilhelm, Manal Zabalawi, Jason M Grayson, et al.
Pageof 5